These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 31534335)
1. Co-disposition of chitosan nanoparticles by multi types of hepatic cells and their subsequent biological elimination: the mechanism and kinetic studies at the cellular and animal levels. Jiang LQ; Wang TY; Wang Y; Wang ZY; Bai YT Int J Nanomedicine; 2019; 14():6035-6060. PubMed ID: 31534335 [No Abstract] [Full Text] [Related]
2. Intracellular disposition of chitosan nanoparticles in macrophages: intracellular uptake, exocytosis, and intercellular transport. Jiang LQ; Wang TY; Webster TJ; Duan HJ; Qiu JY; Zhao ZM; Yin XX; Zheng CL Int J Nanomedicine; 2017; 12():6383-6398. PubMed ID: 28919742 [TBL] [Abstract][Full Text] [Related]
4. Surface chemistry governs the sub-organ transfer, clearance and toxicity of functional gold nanoparticles in the liver and kidney. Li X; Wang B; Zhou S; Chen W; Chen H; Liang S; Zheng L; Yu H; Chu R; Wang M; Chai Z; Feng W J Nanobiotechnology; 2020 Mar; 18(1):45. PubMed ID: 32169073 [TBL] [Abstract][Full Text] [Related]
5. Importance of Hepatic Transporters in Clinical Disposition of Drugs and Their Metabolites. Patel M; Taskar KS; Zamek-Gliszczynski MJ J Clin Pharmacol; 2016 Jul; 56 Suppl 7():S23-39. PubMed ID: 27385177 [TBL] [Abstract][Full Text] [Related]
6. Biological evaluation of N-octyl-O-sulfate chitosan as a new nano-carrier of intravenous drugs. Zhang C; Qu G; Sun Y; Yang T; Yao Z; Shen W; Shen Z; Ding Q; Zhou H; Ping Q Eur J Pharm Sci; 2008 Apr; 33(4-5):415-23. PubMed ID: 18337069 [TBL] [Abstract][Full Text] [Related]
7. Release Properties and Cellular Uptake in Caco-2 Cells of Size-Controlled Chitosan Nanoparticles. Je HJ; Kim ES; Lee JS; Lee HG J Agric Food Chem; 2017 Dec; 65(50):10899-10906. PubMed ID: 29172499 [TBL] [Abstract][Full Text] [Related]
8. Chitosan Nanoparticles Strengthen Vγ9Vδ2 T-Cell Cytotoxicity Through Upregulation Of Killing Molecules And Cytoskeleton Polarization. Lin L; He J; Li J; Xu Y; Li J; Wu Y Int J Nanomedicine; 2019; 14():9325-9336. PubMed ID: 31819434 [TBL] [Abstract][Full Text] [Related]
9. Physiochemical characterization, antioxidative, anticancer cells proliferation and food pathogens antibacterial activity of chitosan nanoparticles loaded with Cyperus articulatus rhizome essential oils. Kavaz D; Idris M; Onyebuchi C Int J Biol Macromol; 2019 Feb; 123():837-845. PubMed ID: 30465833 [TBL] [Abstract][Full Text] [Related]
10. Toxicological Profiling of Metal Oxide Nanoparticles in Liver Context Reveals Pyroptosis in Kupffer Cells and Macrophages versus Apoptosis in Hepatocytes. Mirshafiee V; Sun B; Chang CH; Liao YP; Jiang W; Jiang J; Liu X; Wang X; Xia T; Nel AE ACS Nano; 2018 Apr; 12(4):3836-3852. PubMed ID: 29543433 [TBL] [Abstract][Full Text] [Related]
11. Gadolinium-loaded chitosan nanoparticles as magnetic resonance imaging contrast agents for the diagnosis of tumor. Zhang L; Liu Y; Yu D; Zhangl N J Biomed Nanotechnol; 2013 May; 9(5):863-9. PubMed ID: 23802417 [TBL] [Abstract][Full Text] [Related]
13. Cromolyn chitosan nanoparticles reverse the DNA methylation of RASSF1A and p16 genes and mitigate DNMT1 and METTL3 expression in breast cancer cell line and tumor xenograft model in mice. Motawi TK; El-Maraghy SA; Sabry D; Nady OM; Senousy MA Chem Biol Interact; 2022 Sep; 365():110094. PubMed ID: 35961540 [TBL] [Abstract][Full Text] [Related]
14. Fungal enzyme-mediated synthesis of chitosan nanoparticles and its biocompatibility, antioxidant and bactericidal properties. Saravanakumar K; Chelliah R; MubarakAli D; Jeevithan E; Oh DH; Kathiresan K; Wang MH Int J Biol Macromol; 2018 Oct; 118(Pt B):1542-1549. PubMed ID: 30170364 [TBL] [Abstract][Full Text] [Related]
15. Chitosan nanoparticles alleviated endocrine disruption, oxidative damage, and genotoxicity of Bisphenol-A- intoxicated female African catfish. Hamed HS; Ali RM; Shaheen AA; Hussein NM Comp Biochem Physiol C Toxicol Pharmacol; 2021 Oct; 248():109104. PubMed ID: 34146699 [TBL] [Abstract][Full Text] [Related]
16. Mechanistic Modeling of the Hepatic Disposition of Estradiol-17 Ito K; Sjöstedt N; Brouwer KLR Drug Metab Dispos; 2020 Feb; 48(2):116-122. PubMed ID: 31744810 [TBL] [Abstract][Full Text] [Related]
17. SPION-loaded chitosan-linoleic acid nanoparticles to target hepatocytes. Lee CM; Jeong HJ; Kim SL; Kim EM; Kim DW; Lim ST; Jang KY; Jeong YY; Nah JW; Sohn MH Int J Pharm; 2009 Apr; 371(1-2):163-9. PubMed ID: 19138733 [TBL] [Abstract][Full Text] [Related]
18. Chitosan nanoparticles encapsulating lemongrass (Cymbopogon commutatus) essential oil: Physicochemical, structural, antimicrobial and in-vitro release properties. Soltanzadeh M; Peighambardoust SH; Ghanbarzadeh B; Mohammadi M; Lorenzo JM Int J Biol Macromol; 2021 Dec; 192():1084-1097. PubMed ID: 34673101 [TBL] [Abstract][Full Text] [Related]
19. Macrophage-Mediated Exocytosis of Elongated Nanoparticles Improves Hepatic Excretion and Cancer Phototherapy. Oh N; Kim Y; Kweon HS; Oh WY; Park JH ACS Appl Mater Interfaces; 2018 Aug; 10(34):28450-28457. PubMed ID: 30067899 [TBL] [Abstract][Full Text] [Related]
20. Hepatocyte growth factor incorporated chitosan nanoparticles differentiate murine bone marrow mesenchymal stem cell into hepatocytes in vitro. Pulavendran S; Rajam M; Rose C; Mandal AB IET Nanobiotechnol; 2010 Sep; 4(3):51-60. PubMed ID: 20726671 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]